CTRI/2024/02/062655
Completed
未知
To evaluate effect of immunotherapy on clinical parameters using PET CT Scan in patients diagnosed with metastatic or recurrent unresectable head and neck cancer-a retrospective observational study - NI
HCG NCHRI Cancer Centre0 sites10 target enrollmentTBD
Overview
- Phase
- 未知
- Intervention
- Not specified
- Conditions
- Health Condition 1: - Health Condition 2: C00-C14- Malignant neoplasms of lip, oral cavity and pharynx
- Sponsor
- HCG NCHRI Cancer Centre
- Enrollment
- 10
- Status
- Completed
- Last Updated
- last year
Overview
Brief Summary
No summary available.
Investigators
Eligibility Criteria
Inclusion Criteria
- •Recurrent and Metastatic head and neck cancer patients who received Immunotherapy from September 2022 to September 2023
Exclusion Criteria
- •study does not have exclusion criteria
Outcomes
Primary Outcomes
Not specified
Similar Trials
Completed
Not Applicable
Clinical study for evaluating immunological efficacy of Glypican-3 peptide vaccine in patients with advanced Hepatocellular carcinomaHepatocellular Carcinoma (HCC)JPRN-UMIN000005093Section for Cancer Immunotherapy, Investigative Treatment Division, Research Center for Innovative Oncology, National Cancer Center Hospital East20
Recruiting
Phase 2
Efficacy stem cells in improving the symptoms of patients with lupusIRCT20130812014333N182Kermanshah University of Medical Sciences20
Recruiting
Not Applicable
Clinical study on the clinical efficacy and immune function of anticancer prescription combined with chemotherapy in patients with bladder cancerITMCTR1900002444Dongzhimen Hospital Affiliated to Beijing University of Chinese Medicine
Recruiting
Not Applicable
Study protocol for the HARMONY studyKCT0005173Korea Institute of Oriental Medicine200
Completed
Phase 1
Assessment of efficacy and safety of immunotherapy for unresectable locally advanced pancreatic cancer.pancreatic ductal carcinomaJPRN-UMIN000000769agoya University Hospital15